Kite Pharma, Inc. Business Combination, Contingent Consideration, Liability
Kite Pharma, Inc. had Business Combination, Contingent Consideration, Liability of $14.22 million as of 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2017-02-28
- 2016-12-31: Business Combination, Contingent Consideration, Liability $14.22M.
- 2015-12-31: Business Combination, Contingent Consideration, Liability $16.08M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2016-12-31 | $14.22M 10-K · filed 2017-02-28 |
| 2015-12-31 | $16.08M 10-K · filed 2017-02-28 |